Cover Image
市場調查報告書

全球脊索瘤臨床實驗檢討

Chordoma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 231145
出版日期 內容資訊 英文 95 Pages
訂單完成後即時交付
價格
Back to Top
全球脊索瘤臨床實驗檢討 Chordoma Global Clinical Trials Review, H1, 2014
出版日期: 2014年02月26日 內容資訊: 英文 95 Pages
簡介

本報告提供全球脊索瘤治療藥的臨床實驗資料,提供各國的趨勢,彙整臨床實驗數,潛力治療藥物,及主要企業和研究機關的臨床實驗狀況,為您概述為以下內容。

目錄

簡介

  • 脊索瘤
  • 報告指南

臨床實驗 各地區

  • 臨床實驗 各國
    • 對臨床實驗有所貢獻的前幾名國家 - 亞太地區
    • 對臨床實驗有所貢獻的前五國 - 歐洲
    • 對臨床實驗有所貢獻的前幾名國家 - 北美

臨床實驗:G7 各國

臨床實驗:G7 各國 各臨床實驗狀態

臨床實驗:E7 各國

臨床實驗:E7 各國 各臨床實驗狀態

臨床實驗 各階段

  • 進行中的臨床實驗 各階段

臨床實驗 各臨床實驗狀態

未完成的臨床實驗

每段時期的實驗人數

有力的贊助商

主要的參與臨床實驗企業

潛力治療藥物

臨床實驗 簡介

  • 臨床實驗概要: 前幾名企業
    • Sarcoma Alliance for Research through Collaboration
    • Novartis AG
  • 臨床實驗概要: 最高級大學 / 研究機關 / 醫院
    • National Cancer Institute
    • Massachusetts General Hospital
    • Children's Oncology Group
    • St. John's Mercy Health Care
    • University of Heidelberg
    • Children's Cancer and Leukaemia Group
    • Istituto Nazionale per lo Studio e la Cura dei Tumori
    • Abramson Cancer Center
    • University of Virginia
    • University of Florida 36

5個主要的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC1997CTIDB

GlobalData's clinical trial report, "Chordoma Global Clinical Trials Review, H1, 2014" provides data on the Chordoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chordoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chordoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Chordoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Chordoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Chordoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Chordoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sarcoma Alliance for Research through Collaboration
      • Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • Children's Oncology Group
      • Clinical Trial Overview of Children's Oncology Group
      • St. John's Mercy Health Care
      • Clinical Trial Overview of St. John's Mercy Health Care
      • University of Heidelberg
      • Clinical Trial Overview of University of Heidelberg
      • Children's Cancer and Leukaemia Group
      • Clinical Trial Overview of Children's Cancer and Leukaemia Group
      • Istituto Nazionale per lo Studio e la Cura dei Tumori
      • Clinical Trial Overview of Istituto Nazionale per lo Studio e la Cura dei Tumori
      • Abramson Cancer Center
      • Clinical Trial Overview of Abramson Cancer Center
      • University of Virginia
      • Clinical Trial Overview of University of Virginia
      • University of Florida
      • Clinical Trial Overview of University of Florida
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Chordoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Chordoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chordoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chordoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Chordoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Chordoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Chordoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Chordoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chordoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Chordoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Chordoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Chordoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chordoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chordoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Chordoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chordoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Chordoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chordoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chordoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. John's Mercy Health Care, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Cancer and Leukaemia Group, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Nazionale per lo Studio e la Cura dei Tumori, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014*
  • Chordoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014*

List of Figures

  • Chordoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Chordoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chordoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chordoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Chordoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Chordoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Chordoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Chordoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chordoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Chordoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Chordoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chordoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chordoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chordoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Chordoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chordoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chordoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top